ME01175B - Nove kombinacije antagonista receptora s-ht3 sa racecadotrilom ili deksecadotrilom - Google Patents
Nove kombinacije antagonista receptora s-ht3 sa racecadotrilom ili deksecadotrilomInfo
- Publication number
- ME01175B ME01175B MEP-2010-168A MEP16810A ME01175B ME 01175 B ME01175 B ME 01175B ME P16810 A MEP16810 A ME P16810A ME 01175 B ME01175 B ME 01175B
- Authority
- ME
- Montenegro
- Prior art keywords
- new combinations
- emetic agent
- enkephalinase inhibitor
- anti emetic
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04290384A EP1563848A1 (en) | 2004-02-12 | 2004-02-12 | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
PCT/IB2005/000351 WO2005079850A1 (en) | 2004-02-12 | 2005-02-14 | New combinations of an anti emetic agent and an enkephalinase inhibitor |
EP05702484A EP1718337B1 (en) | 2004-02-12 | 2005-02-14 | New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril |
Publications (1)
Publication Number | Publication Date |
---|---|
ME01175B true ME01175B (me) | 2013-03-20 |
Family
ID=34684783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2010-168A ME01175B (me) | 2004-02-12 | 2005-02-14 | Nove kombinacije antagonista receptora s-ht3 sa racecadotrilom ili deksecadotrilom |
Country Status (28)
Country | Link |
---|---|
US (1) | US8222294B2 (me) |
EP (2) | EP1563848A1 (me) |
JP (1) | JP4987487B2 (me) |
KR (1) | KR101152308B1 (me) |
CN (1) | CN1917903B (me) |
AT (1) | ATE468138T1 (me) |
AU (1) | AU2005215262B2 (me) |
BR (1) | BRPI0506631B8 (me) |
CA (1) | CA2553827C (me) |
CY (1) | CY1110202T1 (me) |
DE (1) | DE602005021317D1 (me) |
DK (1) | DK1718337T3 (me) |
EA (1) | EA010625B1 (me) |
EC (1) | ECSP066758A (me) |
ES (1) | ES2344909T3 (me) |
HR (1) | HRP20100363T1 (me) |
MA (1) | MA28354A1 (me) |
ME (1) | ME01175B (me) |
NO (1) | NO337320B1 (me) |
NZ (1) | NZ548635A (me) |
PL (1) | PL1718337T3 (me) |
PT (1) | PT1718337E (me) |
RS (1) | RS51329B (me) |
SI (1) | SI1718337T1 (me) |
TN (1) | TNSN06246A1 (me) |
UA (1) | UA88156C2 (me) |
WO (1) | WO2005079850A1 (me) |
ZA (1) | ZA200605872B (me) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
EP2462922A1 (en) * | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
NZ702934A (en) | 2012-06-28 | 2017-02-24 | Mcneil-Ppc Inc | Racecadotril lipid compositions |
NZ702930A (en) * | 2012-06-28 | 2017-05-26 | Mcneil-Ppc Inc | Racecadotril liquid compositions |
US9801819B2 (en) * | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
MA40859A (fr) | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
-
2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/en not_active Withdrawn
-
2005
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/me unknown
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/en active Application Filing
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 EP EP05702484A patent/EP1718337B1/en active Active
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko active IP Right Grant
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de active Active
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 CA CA2553827A patent/CA2553827C/en not_active Expired - Fee Related
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/en unknown
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es active Active
- 2005-02-14 US US10/587,899 patent/US8222294B2/en active Active
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
-
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
-
2010
- 2010-06-29 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ME01175B (me) | Nove kombinacije antagonista receptora s-ht3 sa racecadotrilom ili deksecadotrilom | |
NO20083147L (no) | Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse | |
ATE448303T1 (de) | Vektoren zur gerichteten klonierung | |
WO2006083782A3 (en) | Directed differentiation of embryonic stem cells and uses thereof | |
TW200420573A (en) | Bifunctional heterocyclic compounds and methods of making and using same | |
HK1069586A1 (en) | Anti-her2 antibody variants anti-her2 | |
EP1700120A4 (en) | MARKER FOR OPTICAL NEUROMYELITIS | |
WO2005044093A3 (en) | Delta-9- the treatment of multiple sclerosis | |
MXPA02012410A (es) | Metodo para tratar enfermedades cardiovasculares usando rapamicina. | |
PL1727720T3 (pl) | Kolejowy wózek zwrotny | |
WO2005000208A3 (en) | Combination therapy for the treatment of neoplasms | |
WO2006078998A3 (en) | Methods and compositions for decreasing saliva production | |
TW200712130A (en) | Process oil and rubber composition | |
WO2005118946A3 (en) | Self-steaming benefit composition | |
WO2007132355A3 (en) | Compositions and methods for inhibiting viral adhesion | |
TR200705146T1 (tr) | Monoamin Yükselmesinin Engellenmesi | |
WO2007008769A3 (en) | Use of pseudan and pseudan inclusion bodies | |
TW200745187A (en) | Protecting agent | |
WO2006021451A3 (en) | Methods and compounds for treating diabetes | |
WO2006116687A3 (en) | Nanoassays | |
WO2003099783A3 (en) | Tropane compounds | |
TW200602106A (en) | Exercise aid | |
BR8102665Y1 (pt) | caixa para proteção de válvulas diversas. | |
TW200722490A (en) | Cured coating for use in optics or electronics |